Dr. Reddy’s Laboratories Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +8,569.6% | -1.8% | +8.3% | +4.5% | +4.3% | +1.8% | +0.5% | +3.0% | -0.9% | -12.5% | +6.4% | – | |
| – | +8,143.5% | -2.0% | +3.5% | +6.6% | +6.6% | +9.4% | -2.6% | +8.4% | +1.4% | +4.1% | +3.1% | – | |
| – | +8,899.6% | -1.7% | +11.7% | +3.1% | +2.7% | -3.6% | +2.9% | -1.0% | -2.8% | -26.9% | +10.4% | – | |
| – | +8,346.6% | +23.6% | -9.9% | +17.4% | -8.4% | +9.0% | -14.0% | -0.7% | -0.9% | -9.8% | +4.5% | – | |
| – | -29.9% | +1.2% | +10.8% | +1.4% | +4.8% | -0.3% | -3.6% | +14.0% | -39.9% | -8.9% | +80.4% | – | |
| – | +8,527.3% | +4.9% | +7.1% | +6.3% | +0.4% | -2.4% | +5.2% | -1.7% | +6.3% | +3.6% | +3.1% | – | |
| – | +9,726.2% | -13.4% | +19.8% | -2.1% | +6.7% | -5.7% | -1.0% | +0.2% | -18.7% | -96.7% | +527.9% | – | |
| – | +11.6% | +50.5% | +0.8% | +26.6% | +8.1% | -19.8% | +26.5% | +9.3% | +4.9% | +12.8% | +17.6% | – | |
| – | +7,788.6% | -12.3% | +17.5% | +1.8% | -2.2% | +7.0% | -5.0% | -3.7% | -15.9% | -86.9% | +174.9% | – | |
| – | +8,423.1% | -34.1% | +66.4% | +17.4% | -18.2% | -11.1% | +18.4% | -17.6% | -13.4% | -106.2% | – | – | |
| – | +7,602.7% | -5.2% | +6.5% | -9.8% | +12.6% | +12.8% | -11.0% | +1.4% | -15.8% | -81.5% | +99.6% | – | |
| – | +7,474.3% | -4.5% | +7.1% | +9.8% | +1.6% | +4.1% | -2.5% | -1.4% | -19.5% | -55.2% | -66.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.